The study identified 235 resveratrol-related targets and 510 COVID-19 differential genes. Resveratrol regulates inflammation via IL-17, NF-κB, and TNF signaling pathways, mitigating cytokine storms and acute respiratory distress syndrome. The gene discussed is IL17A; the disease is COVID-19.